Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

1 API Suppliers, 1 USDMF

1 API Suppliers
1 USDMF

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 139145-27-0, Parogrelil [inn], 2pcp9n33nh, 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-((pyridin-3-ylmethyl)amino)pyridazin-3(2h)-one, 5-bromo-3-[3-(4-chlorophenyl)propoxy]-4-(pyridin-3-ylmethylamino)-1h-pyridazin-6-one, Unii-2pcp9n33nh

Molecular Formula

C₁₉H₁₈BrClN₄O₂

Molecular Weight

449.7 g/mol

InChI Key

YJMYSLFFZJUXOA-UHFFFAOYSA-N

FDA UNII

2PCP9N33NH

1 2D Structure

Parogrelil

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

5-bromo-3-[3-(4-chlorophenyl)propoxy]-4-(pyridin-3-ylmethylamino)-1H-pyridazin-6-one

2.1.2 InChI

InChI=1S/C19H18BrClN4O2/c20-16-17(23-12-14-3-1-9-22-11-14)19(25-24-18(16)26)27-10-2-4-13-5-7-15(21)8-6-13/h1,3,5-9,11H,2,4,10,12H2,(H2,23,24,26)

2.1.3 InChI Key

YJMYSLFFZJUXOA-UHFFFAOYSA-N

2.1.4 Canonical SMILES

C1=CC(=CN=C1)CNC2=C(C(=O)NN=C2OCCCC3=CC=C(C=C3)Cl)Br

2.2 Other Identifiers

2.2.1 UNII

2PCP9N33NH

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-(3-pyridylmethylamino)-3(2h)-pyridazinone Hydrochloride

2. Nm-702

3. Nt 702

4. Nt-702

5. Nt702 Cpd

6. Parogrelil Hydrochloride

2.3.2 Depositor-Supplied Synonyms

1. 139145-27-0

2. Parogrelil [inn]

3. 2pcp9n33nh

4. 4-bromo-6-(3-(4-chlorophenyl)propoxy)-5-((pyridin-3-ylmethyl)amino)pyridazin-3(2h)-one

5. 5-bromo-3-[3-(4-chlorophenyl)propoxy]-4-(pyridin-3-ylmethylamino)-1h-pyridazin-6-one

6. Unii-2pcp9n33nh

7. Nt 702, Free Base

8. Mls006010243

9. Schembl149290

10. Dtxsid80930371

11. Bcpp000130

12. Bcp02174

13. Zinc1539352

14. Nt-702

15. Bcp9001051

16. Sb16958

17. Ncgc00346449-01

18. Ncgc00346449-02

19. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2h)-one Hydrochloride (free Base)

20. Smr004701319

21. Ds-016806

22. 145p270

23. Q27255385

24. 4-bromo-5-(3-pyridylmethylamino)-6-(3-(4-chlorophenyl) Propoxy)-3-(2h)pyridazinone

25. 4-bromo-5-[(3-pyridyl)methylamino]-6-[3-(4-chlorophenyl)propoxy]pyridazine-3(2h)-one

26. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-{[(pyridin-3-yl)methyl]amino}pyridazin-3-ol

27. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-(pyridin-3-ylmethylamino)pyridazin-3(2h)-one Hydrochloride (

28. 4-bromo-6-[3-(4-chlorophenyl)propoxy]-5-[(pyridin-3-ylmethyl)amino]-2,3-dihydropyridazin-3-one

2.4 Create Date

2006-10-25

3 Chemical and Physical Properties

Molecular Formula	C₁₉H₁₈BrClN₄O₂
Molecular Weight	449.7 g/mol
XLogP3	4.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	5
Rotatable Bond Count	8
Exact Mass	448.03017 g/mol
Monoisotopic Mass	448.03017 g/mol
Topological Polar Surface Area	75.6 Å²
Heavy Atom Count	27
Formal Charge	0
Complexity	576
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1